Fresenius SE KGaA (LTS:0OO9) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0OO9 Fresenius SE & Co KGaA LTS:0OO9
69 GF Score
Price €41.83
GF Value €36.73
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0OO9 vs HCA, THC, DVA: Short Interest Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius SE KGaA Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Short Interest distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Short Interest falls into.


LTS:0OO9
69GF Score
Fresenius SE & Co KGaA LTS:0OO9
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fresenius SE KGaA (LTS:0OO9) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of €41.83 is trading 13.9% above its estimated GF Value™ of €36.73. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for LTS:0OO9:

  • Short Interest:
  • GF Value™: €36.73 vs. price of €41.83 (13.9% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the LTS:0OO9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
69GF Score

Get the complete analysis for LTS:0OO9

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.83
Price
€36.73
GF Value